← Back to Search

Unknown

AZD5462 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by AstraZeneca
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 to day 17
Awards & highlights

Study Summary

This trial will study how a new drug is absorbed by the body and how it is broken down.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 to day 17
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 to day 17 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under plasma concentration time curve from zero to infinity (AUCinf)
Area under the plasma concentration-curve from time zero to last quantifiable concentration (AUClast)
Maximum observed plasma (peak) drug concentration [Cmax]
Secondary outcome measures
Number of participants with Adverse Events (AEs), and Serious Adverse Events (SAEs)

Trial Design

6Treatment groups
Experimental Treatment
Group I: Treatment FExperimental Treatment1 Intervention
Participants will receive Dose C orally as a film-coated tablet.
Group II: Treatment EExperimental Treatment1 Intervention
Participants will receive Dose C orally as a film-coated tablet.
Group III: Treatment DExperimental Treatment1 Intervention
Participants will receive Dose B orally as an oral solution.
Group IV: Treatment CExperimental Treatment1 Intervention
Participants will receive Dose B orally as a film-coated tablet.
Group V: Treatment BExperimental Treatment1 Intervention
Participants will receive Dose A orally as a film-coated tablet.
Group VI: Treatment AExperimental Treatment1 Intervention
Participants will receive Dose A orally as a film-coated tablet.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AZD5462
2022
Completed Phase 1
~150

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

AstraZenecaLead Sponsor
4,265 Previous Clinical Trials
288,605,266 Total Patients Enrolled
ParexelIndustry Sponsor
303 Previous Clinical Trials
100,810 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers
2022. "A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05512806.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top